Current Medicines
For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs. Our growing portfolio of medicines includes treatments in the areas of cardiovascular, diabetes, men’s health, musculoskeletal, neuroscience and oncology.
New Zealand laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information about a Lilly product that has been prescribed to them, to speak to their healthcare professional.
The product information on this website is intended for New Zealand residents.
Diabetes
Humalog ® / Humalog ® Mix25 / Humalog ® Mix50 (insulin lispro) cartridges
Humalog ® (insulin lispro) vials
Humulin ® R/Humulin ® NPH/ Humulin ® 30/70 (biosynthetic human insulin) vials
Humulin ® R/ Humulin ® NPH/ Humulin ® 30/70 (biosynthetic human insulin) cartridges
Diabetes – In alliance with Boehringer Ingelheim
Jardiance ® * (empagliflozin)
Jardiamet ® * (empagliflozin / metformin hydrochloride)
* A licensed trademark of Boehringer Ingelheim
Men's Health
Cialis® (tadalafil)
Musculoskeletal
Evista® (raloxifene hydrochloride)
Forteo® (teriparatide of recombinant DNA origin)
Neuroscience
Prozac® (fluoxetine hydrochloride)
Strattera® (atomoxetine hydrochloride)
Zyprexa® (olanzapine) – Tablets and Wafers
Zyprexa® IM (olanzapine) – Injection
Zyprexa® Relprevv (olanzapine) long acting injectable
Oncology
Alimta® (pemetrexed)
PP-MG-NZ-0019 04/2021